Nyxoah (NYXH) has released an update.
Nyxoah SA, a medical technology firm specializing in solutions for Obstructive Sleep Apnea Syndrome, will release its financial results for Q2 and the first half of 2024 on August 6, 2024. The announcement will be followed by a management-hosted conference call, with access details available on the company’s Investor Relations webpage. Nyxoah’s Genio system, a notable product for OSAS, has received CE marking and is the focal point of the company’s development and commercialization efforts.
For further insights into NYXH stock, check out TipRanks’ Stock Analysis page.
